- Home
- RVPH vs CLPS Comparison
RVPH vs CLPS Comparison
Compare RVPH & CLPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVPH
- CLPS
- Stock Information
- Founded
- RVPH 2006
- CLPS 2005
- Country
- RVPH United States
- CLPS Hong Kong
- Employees
- RVPH N/A
- CLPS N/A
- Industry
- RVPH Biotechnology: Pharmaceutical Preparations
- CLPS Computer Software: Prepackaged Software
- Sector
- RVPH Health Care
- CLPS Technology
- Exchange
- RVPH Nasdaq
- CLPS Nasdaq
- Market Cap
- RVPH 32.8M
- CLPS 26.0M
- IPO Year
- RVPH N/A
- CLPS 2018
- Fundamental
- Price
- RVPH $0.40
- CLPS $0.97
- Analyst Decision
- RVPH Strong Buy
- CLPS
- Analyst Count
- RVPH 5
- CLPS 0
- Target Price
- RVPH $9.00
- CLPS N/A
- AVG Volume (30 Days)
- RVPH 3.4M
- CLPS 11.8K
- Earning Date
- RVPH 08-13-2025
- CLPS 03-05-2025
- Dividend Yield
- RVPH N/A
- CLPS 13.35%
- EPS Growth
- RVPH N/A
- CLPS N/A
- EPS
- RVPH N/A
- CLPS N/A
- Revenue
- RVPH N/A
- CLPS $153,816,045.00
- Revenue This Year
- RVPH N/A
- CLPS N/A
- Revenue Next Year
- RVPH N/A
- CLPS N/A
- P/E Ratio
- RVPH N/A
- CLPS N/A
- Revenue Growth
- RVPH N/A
- CLPS 5.81
- 52 Week Low
- RVPH $0.30
- CLPS $0.68
- 52 Week High
- RVPH $4.28
- CLPS $1.70
- Technical
- Relative Strength Index (RSI)
- RVPH 33.44
- CLPS 45.57
- Support Level
- RVPH $0.35
- CLPS $0.90
- Resistance Level
- RVPH $0.83
- CLPS $0.94
- Average True Range (ATR)
- RVPH 0.06
- CLPS 0.04
- MACD
- RVPH -0.01
- CLPS -0.00
- Stochastic Oscillator
- RVPH 17.36
- CLPS 38.46
About RVPH Reviva Pharmaceuticals Holdings Inc.
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease and Parkinson's disease psychosis and its other drug candidate is RP1208.
About CLPS CLPS Incorporation
CLPS Inc is a holding company. The company through its subsidiaries provides information technology consulting and solutions institutions in the banking, insurance, and financial sectors, both in China and globally. Its products are Risk Control Platform, Transaction Acquiring Platform, Debt Collection Platform, Virtual Bank Training Platform, Credit Card System, and other related products. The company generates its revenue from IT consulting services, Customized IT solution services, and others. Generating the majority of its revenue from the IT consulting service.